BAX · Baxter International Inc

$25.58 -0.25 (-0.97%)

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$13.35B

517.00M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Andrew Hider	President and CEO	$499,315	$1,000,000	$23,133,518	$3,185,053	$820,125	$1,167,171	$29,805,182
Joel Grade	Former Executive Vice President and CFO	$827,825	—	$5,809,671	$1,049,372	$459,000	$63,700	$8,209,568
José Almeida	Former Chair of the Board, President and CEO	$660,420	—	—	—	—	$7,005,624	$7,666,044
Heather Knight	Former Executive Vice President, COO and Interim Group President, Medical Products & Therapies	$747,123	—	$4,018,281	$1,267,349	—	$41,795	$6,074,548
Reazur Rasul	Executive Vice President and Group President, Healthcare Systems & Technologies	$800,000	—	$2,953,421	$931,507	$488,000	$73,286	$5,246,214
Alok Sonig	Former Executive Vice President and Group President, Pharmaceuticals	$779,747	—	$3,375,371	$1,064,578	—	$19,577	$5,239,273
Brent Shafer	Non-Executive Chair and Former Executive Chair and Interim CEO	$701,644	$654,839	$2,400,815	—	—	$52,695	$3,809,993
David Rosenbloom	Executive Vice President and General Counsel	$760,000	—	$1,989,036	$627,345	$348,840	$68,943	$3,794,164
Cecilia Soriano	Group President, Infusion Therapies & Technologies and Pharmaceuticals	$668,247	$75,000	$1,300,147	$253,472	$291,732	$66,243	$2,654,841

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
José Almeida	Former Chair of the Board, President and Chief Executive Officer	$1,300,000	—	$14,319,107	—	$2,016,300	$435,608	$18,071,015
Christopher Toth	Former Executive Vice President and Group President, Kidney Care	$1,000,000	—	$5,119,077	—	$1,387,500	$78,224	$7,584,801
Heather Knight	Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products & Therapies	$883,333	—	$4,607,152	—	$1,039,500	$66,505	$6,596,490
Joel Grade	Executive Vice President and Chief Financial Officer	$810,000	$500,000	$4,295,702	—	$839,608	$62,238	$6,507,548
Alok Sonig	Executive Vice President and Group President, Pharmaceuticals	$787,500	—	$3,583,345	—	$904,000	$70,961	$5,345,806

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
José Almeida	Former Chair of the Board, President and Chief Executive Officer	$1,300,000	—	$7,527,469	$2,635,170	$2,187,900	$136,132	$13,786,671
Christopher Toth	Former Executive Vice President and Group President, Kidney Care	$586,301	$3,200,000	$4,385,140	—	$730,238	$738,636	$9,640,315
Cristiano Franzi	Former Senior Vice President and President, EMEA	$525,373	—	$2,674,998	$598,904	$455,498	$2,630,134	$6,884,907
Joel Grade	Executive Vice President and Chief Financial Officer	$164,384	—	$3,636,661	$902,897	$167,671	$4,608	$4,876,222
Heather Knight	Executive Vice President, Chief Operating Officer and Interim Group President, Medical Products & Therapies	$791,507	—	$2,395,122	$838,466	$771,091	$64,057	$4,860,243
Alok Sonig	Executive Vice President and Group President, Pharmaceuticals	$725,000	—	$1,710,802	$598,904	$794,568	$36,759	$3,866,033
James Saccaro	Former Executive Vice President and Chief Financial Officer	$354,628	—	$2,463,534	$862,417	—	$25,174	$3,705,753
Brian Stevens	CFO	$517,471	$350,000	$1,142,141	$131,756	$344,097	$43,836	$2,529,301
Brian C. Stevens	Senior Vice President, Chief Accounting Officer & Controller and Former Interim Chief Financial Officer	$517,471	$350,000	$1,142,141	$131,756	$344,097	$43,836	$2,529,301

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
José Almeida	Former Chair of the Board, President and Chief Executive Officer	$1,300,000	—	$8,730,301	$2,760,487	$675,675	$121,773	$13,588,236
James Saccaro	Former Executive Vice President and Chief Financial Officer	$834,638	—	$6,099,090	$903,428	$267,750	$102,263	$8,207,169
Giuseppe Accogli	Executive Vice President and Chief Operating Officer	$875,000	—	$5,876,277	$1,003,817	—	$106,155	$7,861,249
David Rosenbloom	Senior Vice President and General Counsel	$512,466	—	$4,308,943	$577,356	$137,213	$24,338	$5,560,316
Cristiano Franzi	Former Senior Vice President and President, EMEA	$824,415	—	$3,263,287	$690,122	$310,475	$169,217	$5,257,516

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
José Almeida	Chair of the Board, President and Chief Executive Officer	$1,300,000	—	$6,476,195	$5,443,374	$2,364,863	$50,302	$15,634,734
Giuseppe Accogli	Executive Vice President and Chief Operating Officer	$824,403	—	$2,152,605	$1,905,180	$893,025	$64,827	$5,840,040
Andrew Frye	Senior Vice President, and President, APAC	$740,423	—	$1,795,080	$1,237,135	$673,845	$262,116	$4,708,599
James Saccaro	Former Executive Vice President and Chief Financial Officer	$757,142	—	$1,551,519	$1,286,620	$797,052	$66,182	$4,458,515
Cristiano Franzi	Former Senior Vice President and President, EMEA	$809,079	—	$1,412,782	$1,237,135	$782,424	$165,946	$4,407,366

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
José Almeida	Chair, President and Chief Executive Officer	$1,300,000	—	$8,374,122	$6,120,424	—	$70,850	$15,865,396
Giuseppe Accogli	Executive Vice President and Chief Operating Officer	$774,891	—	$2,020,329	$1,530,102	$230,400	$88,545	$4,644,267
Sean Martin	Senior Vice President and General Counsel	$672,311	—	$2,258,844	$816,052	$222,220	$48,916	$4,018,343
Cristiano Franzi	Senior Vice President and President, EMEA	$821,481	—	$1,364,748	$1,020,073	$336,297	$169,066	$3,711,665
James Saccaro	Executive Vice President and Chief Financial Officer	$739,000	—	$1,181,783	$663,040	$287,820	$53,544	$3,201,182

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
José Almeida	Chairman of the Board, President and Chief Executive Officer	$1,300,000	—	$6,648,082	$5,146,807	$690,750	$128,182	$13,913,821
James Saccaro	Executive Vice President and Chief Financial Officer	$735,805	—	$1,678,374	$1,338,176	—	$99,228	$4,169,599
Giuseppe Accogli	Executive Vice President and Chief Operating Officer	$731,370	—	$1,387,463	$1,132,294	$691,790	$94,037	$4,036,954
Sean Martin	Senior Vice President and General Counsel	$648,677	—	$1,063,671	$823,485	$593,940	$83,299	$3,213,072
Cristiano Franzi	Senior Vice President and President, EMEA	$727,634	—	$844,488	$823,485	$611,224	$160,879	$3,167,710

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
José Almeida	Chairman of the Board, Chief Executive Officer and President	$1,300,000	—	$6,728,166	$4,899,990	$2,582,450	$134,519	$15,645,125
James Saccaro	Executive Vice President and Chief Financial Officer	$714,485	—	$1,667,170	$1,273,996	$883,650	$115,460	$4,654,761
Giuseppe Accogli	Senior Vice President and President, Americas & Global Business Units	$706,597	—	$1,072,958	$979,998	$827,480	$186,536	$3,773,569
Sean Martin	Senior Vice President and General Counsel	$632,781	—	$853,539	$784,004	$695,960	$82,214	$3,048,498

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
José Almeida	Chairman of the Board, Chief Executive Officer and President	$1,300,000	—	$5,373,599	$5,185,130	$2,808,000	$266,935	$14,933,664
James Saccaro	Executive Vice President and Chief Financial Officer	$681,658	—	$5,863,351	$1,140,729	$1,108,800	$110,970	$9,044,664
Sean Martin	Senior Vice President and General Counsel	$521,479	$500,000	$1,704,447	$2,284,047	$694,400	$16,324	$5,720,697
Giuseppe Accogli	Senior Vice President and President, Americas	$632,986	—	$2,335,306	$907,399	$1,012,000	$139,813	$5,027,504

Executive changes

Person	Role	Change	Effective	Filed
Bernie Heine	Associate Vice President, Finance, interim Chief Accounting Officer (“CAO”) and Controller	Appointed	2026-09-15	2026-08-19
Andrew Hider	interim CFO	Appointed	2026-09-15	2026-08-19
John Rogers	Executive Vice President and Chief Financial Officer	Appointed	2026-10-01	2026-08-19
Anita Zielinski	Senior Vice President, Chief Accounting Officer and Controller	Resigned	2026-09-15	2026-08-04
Anita Zielinski	Interim Chief Financial Officer	Resigned	2026-09-15	2026-08-04
David S. Wilkes, M.D.	director	Appointed	2026-05-05	2026-05-08
Brent Shafer	director	Appointed	2026-05-05	2026-05-08
Amy A. Wendell	director	Appointed	2026-05-05	2026-05-08
Nancy M. Schlichting	director	Appointed	2026-05-05	2026-05-08
Michael R. McDonnell	director	Appointed	2026-05-05	2026-05-08
Patricia B. Morrison	director	Appointed	2026-05-05	2026-05-08
Jeffrey A. Craig	director	Appointed	2026-05-05	2026-05-08
Andrew P. Hider	director	Appointed	2026-05-05	2026-05-08
William A. Ampofo II	director	Appointed	2026-05-05	2026-05-08
Anita Zielinski	Interim Chief Financial Officer	Appointed	2026-03-16	2026-03-16
Stephen H. Rusckowski	member of the Board	Resigned	2026-02-13	2026-02-12
Cathy R. Smith	member of the Board	Resigned	2026-02-13	2026-02-12
Michael R. McDonnell	Board of Directors	Appointed	2026-02-13	2026-02-12
Alok Sonig	Executive Vice President and Group President, Pharmaceuticals	Resigned	2025-12-01	2025-11-12
Andrew Hider	interim group president of MPT	Appointed	2025-10-29	2025-10-21
Heather Knight	interim group president of Medical Products and Therapies ("MPT")	Resigned	2025-10-29	2025-10-21
Heather Knight	Executive Vice President, Chief Operating Officer	Resigned	2025-10-29	2025-10-21
Andrew Hider	Director	Appointed	2025-09-03	2025-07-07
Andrew Hider	President and Chief Executive Officer	Appointed	2025-09-03	2025-07-07

Key facts CIK 10456 CUSIP 071813109 13F (30d) 330 filings 327 filers Visit website Investor relations